Biogen Stock Rockets On Posivie Tecfidera Patent Decision – Investor's Business Daily
Business News
- Biogen Stock Rockets On Posivie Tecfidera Patent Decision Investor’s Business Daily
- Biogen wins Tecfidera patent challenge from Mylan, sending shares way up FiercePharma
- Biogen wins patent challenge to key multiple sclerosis drug STAT
- Biogen shares soar 27% on patent win over Mylan for MS drug Reuters
- Biogen shares soar after patent victory Financial Times
- View full coverage on Google News
Source: Business News